Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account
Immunoprobe, Inc. — Predicate Candidate Screening
14 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.
203 daysmedian FDA review time
253 days90th percentile
14clearances measured
| K-number | Device | Applicant | Decided | Review days | Recalls (K-match) |
|---|---|---|---|---|---|
| K972406 | ADENOVIRUS ANTIGEN DETECTION ELISA TEST SYSTEM | Immunoprobe, Inc. | 1997-12-22 | 179 | 0 |
| K971393 | MYCOPLASMA IGG ELISA TEST SYSTEM | Immunoprobe, Inc. | 1997-07-14 | 96 | 0 |
| K961765 | MPO ELISA TEST SYSTEM | Immunoprobe, Inc. | 1996-08-19 | 104 | 0 |
| K961764 | PR-3 ELISA TEST SYSTEM | Immunoprobe, Inc. | 1996-08-19 | 104 | 0 |
| K951549 | EBNA IGG EIA TEST SYSTEM | Immunoprobe, Inc. | 1996-04-29 | 391 | 0 |
| K952523 | CARDIOLIPIN IGG EIA TEST KIT | Immunoprobe, Inc. | 1996-02-09 | 253 | 0 |
| K952521 | CARDIOLIPIN IGM EIA TEST SYSTEM | Immunoprobe, Inc. | 1996-02-09 | 253 | 0 |
| K952522 | CARDIOLIPIN IGA EIA TEST SYSTEM | Immunoprobe, Inc. | 1996-02-09 | 253 | 0 |
| K951362 | THYROGLOBULIN EIA TEST KIT | Immunoprobe, Inc. | 1995-11-20 | 241 | 0 |
| K951364 | MICROSOMAL EIA TEST KIT | Immunoprobe, Inc. | 1995-11-20 | 241 | 0 |
| K951363 | CARDIOLIPIN IGG,M,A EIA TEST SYSTEM | Immunoprobe, Inc. | 1995-10-13 | 203 | 0 |
| K952520 | CARDIOLIPIN IGG,M,A EIA TEST KIT | Immunoprobe, Inc. | 1995-09-15 | 106 | 0 |
| K941361 | MICROSOMAL EIA TEST KIT | Immunoprobe, Inc. | 1994-05-11 | 51 | 0 |
| K941358 | THYROGLOBULIN EIA TEST KIT | Immunoprobe, Inc. | 1994-05-11 | 51 | 0 |
Methodology
Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.
Prepared with Atlas
Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda